54 171

Cited 0 times in

TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.

Authors
Kim, H; Oda, T; López-Guisa, J; Wing, D; Edwards, DR; Soloway, PD; Eddy, AA
Citation
Journal of the American Society of Nephrology : JASN, 12(4):736-748, 2001
Journal Title
Journal of the American Society of Nephrology : JASN
ISSN
1046-66731533-3450
Abstract
Progressive renal disease as a result of renal fibrosis is caused in part by an impairment of the proteolytic machinery that normally regulates matrix turnover. The goal of the present study was to determine whether genetic deficiency of tissue inhibitor of metalloproteinases-1 (TIMP-1) could attenuate interstitial fibrosis caused by unilateral ureteral obstruction (UUO). Groups of wild-type (Timp-1) mice and TIMP-1-deficient (timp-1) mice were killed after 3 and 14 d of UUO or sham operation. Timp-1 mRNA levels were significantly increased 37- and 19-fold in the wild-type mice 3 and 14 d, respectively, after UUO operation. Matrix metalloproteinase-9 (MMP-9) activity fell in all UUO groups but remained significantly higher in the timp-1 group compared with the Timp-1 group. The degree of interstitial fibrosis (kidney collagen content and percentage of tubulointerstitial area stained with picrosirius red and collagen III) was significantly increased 14 d after UUO operation, but there was no difference between the Timp-1 and timp-1 groups. Many features of the fibrogenic response were similar between the Timp-1 and timp-1 groups, including the number of myofibroblasts and the induction of genes encoding procollagen III, fibronectin, and transforming growth factor-beta. After UUO operation, renal mRNA levels for Timp-3 and plasminogen activator inhibitor-1 were significantly higher in the TIMP-1-deficient mice. The results of this study show that elimination of TIMP-1 alone does not alter the severity of interstitial fibrosis. These findings may be due to compensation by other protease inhibitors such as TIMP-2, TIMP-3, and/or plasminogen activator inhibitor-1 or to the possibility that inhibition of intrinsic MMP activity does not constitute a profibrogenic event in the kidney.
MeSH terms
AnimalsApoptosisBlotting, WesternBody WeightFibroblasts/pathologyFibrosisGelatinases/geneticsGene ExpressionKidney/metabolismKidney/pathology*Kidney Tubules/pathologyKidney Tubules/physiopathologyMacrophages/pathologyMatrix Metalloproteinase 9/metabolismMetalloendopeptidases/metabolismMiceMuscle, Smooth/pathologyOrgan SizeProcollagen/geneticsSeverity of Illness IndexTissue Inhibitor of Metalloproteinase-1/deficiency*Tissue Inhibitor of Metalloproteinase-1/geneticsTransforming Growth Factor beta/geneticsUreteral Obstruction/pathology*
PMID
11274235
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Nephrology
AJOU Authors
김, 흥수
Full Text Link
Files in This Item:
Full-Text Not Available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse